CN105949075B - A kind of synthetic method of mefenamic acid - Google Patents

A kind of synthetic method of mefenamic acid Download PDF

Info

Publication number
CN105949075B
CN105949075B CN201610475862.9A CN201610475862A CN105949075B CN 105949075 B CN105949075 B CN 105949075B CN 201610475862 A CN201610475862 A CN 201610475862A CN 105949075 B CN105949075 B CN 105949075B
Authority
CN
China
Prior art keywords
chloro
synthetic method
acid
mefenamic acid
benzoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610475862.9A
Other languages
Chinese (zh)
Other versions
CN105949075A (en
Inventor
吴文良
卢小逸
张启明
王诚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHEJIANG QIMING PHARMACEUTICAL CO Ltd
Jiangsu Beihede Chemistry Co Ltd
Original Assignee
ZHEJIANG QIMING PHARMACEUTICAL CO Ltd
Jiangsu Beihede Chemistry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZHEJIANG QIMING PHARMACEUTICAL CO Ltd, Jiangsu Beihede Chemistry Co Ltd filed Critical ZHEJIANG QIMING PHARMACEUTICAL CO Ltd
Priority to CN201610475862.9A priority Critical patent/CN105949075B/en
Publication of CN105949075A publication Critical patent/CN105949075A/en
Application granted granted Critical
Publication of CN105949075B publication Critical patent/CN105949075B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses a kind of synthetic method of mefenamic acid, using 0-chloro-benzoic acid as raw material, in the presence of acid binding agent, using aprotic polar solvent, 0-chloro-benzoic acid salt is obtained into salt;Under dehydrating agent effect, using manganese powder or manganese salt as catalyst, 0-chloro-benzoic acid salt and 2, the progress condensation reaction of 3 dimethylanilines, then acidified obtain mefenamic acid.The invention provides a kind of synthetic method of mefenamic acid, have the advantages that reaction yield is high, product qualities are high and production cost is low, the problem of solving relatively low product yield present in existing preparation method and deeper product colour.

Description

A kind of synthetic method of mefenamic acid
Technical field
The present invention relates to the technical field of organic synthesis, more particularly to a kind of synthetic method of mefenamic acid.
Background technology
Mefenamic acid, also known as mefenamic acid, flutter hot pain etc., English entitled Mefenamic Acid, chemical entitled N-2,3- bis- Tolyl ortho-aminobenzoic acid, structural formula is shown below.
Mefenamic acid is a kind of NSAIDs, and main function is the synthesis and suppression albumen by suppressing prostaglandin Matter catabolic enzyme, so that the protein structure of stabilizing cell membrane, disturbs tissue metabolism's process and play a role.
Compared with the NSAIDs of same type, the antiinflammatory action of mefenamic acid is significantly stronger than flufenamic acid and clofenamic acid, Therefore it is more widely applied.Clinically it is mainly used in rheumatic, rheumatoid arthritis, dysmenorrhoea, headache, neuralgia, courbature And the treatment of other postoperative inflammatory pains.In addition, mefenamic acid can be additionally used in the precursor of acridine antimalarial and anticarcinogen.
The synthesis of mefenamic acid traditional in early days, which is mainly first to react 0-chloro-benzoic acid and inorganic base, first generates adjacent chlorobenzene Formic acid sodium salt, 0-chloro-benzoic acid sodium salt is made with 2,3- dimethylanilines in aqueous phase condensation again, but product yield is relatively low, causes life Production cost is higher and is eliminated.
Because DMF, DMSO and sulfolane equal solvent have certain dissolubility to 0-chloro-benzoic acid sodium salt, therefore later conjunction Water substantially is instead of with DMF, DMSO and sulfolane equal solvent into method, and achieves preferable conversion ratio.
The documents such as CN200910154422.3 and CN200910114917.3 refer to 0-chloro-benzoic acid and 2,3- dimethyl Aniline is achieved very well using copper chloride, copper sulphate, copper nitrate, copper acetate, cupric oxide and copper powder etc. as condensation catalyst Yield, but in course of reaction particularly reaction the later stage generate a large amount of tar, obtained mefenamic acid crude product color is partially deep, lead to Often be atropurpureus, and containing certain tar, viscosity is larger, even if by solvent refining lighter, but losing larger, more by In the factor of copper ion, product often greening, not enough in vain.Therefore the synthetic method also has certain limitation.
The content of the invention
The invention provides a kind of synthetic method of mefenamic acid, with reaction yield is high, product qualities are high and produce The low advantage of cost, the problem of solving relatively low product yield present in existing preparation method and deeper product colour.
The invention discloses a kind of synthetic method of mefenamic acid, comprise the following steps:
(1) using 0-chloro-benzoic acid as raw material, in the presence of acid binding agent, using aprotic polar solvent, adjacent chlorine is obtained into salt Benzoate;
(2) under dehydrating agent effect, using manganese powder or manganese salt as catalyst, 0-chloro-benzoic acid salt and 2,3- dimethyl benzene Amine carries out condensation reaction, then acidified obtains mefenamic acid.
The present invention mainly starts with from the catalyst of condensation reaction, abandons the use of copper powder and copper-containing compound, uses metal instead Manganese powder or manganese salt, reaction side reaction are significantly reduced, while reducing tar yield, product appearance improves obvious.
Preferably, in above-mentioned synthetic method:
0-chloro-benzoic acid, 23 dimethyl aniline, the mass ratio of acid binding agent and catalyst are 1:0.8~1.0:0.8~ 1.2:0.01~0.03;
The mass ratio of aprotic polar solvent and 0-chloro-benzoic acid is 0.3~0.5:1;
The mass ratio of dehydrating agent and 0-chloro-benzoic acid is 0.8~1.2:1.
Preferably, in step (1), described acid binding agent is sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide.
In the present invention, abandon water and make solvent, reaction dissolvent is used as using aprotic polar solvent so that yield is carried It is high.Preferably, in step (1), described aprotic polar solvent is DMF, DMSO or sulfolane.
To ensure being completely dissolved and abundant into salt for 0-chloro-benzoic acid, preferably, in step (1), dissolving and anti-into salt It should be carried out in the case where being heated to 80 DEG C.
Because condensation reaction generates water, dehydrating agent is introduced, the water for reacting generation is removed in time using azeotropic, greatly shortened Reaction time.Preferably, in step (2), described dehydrating agent is benzene or toluene.
Preferably, in step (2), described manganese salt is manganese acetate or manganese sulfate.
Preferably, in step (2), the temperature of the condensation reaction is 120~130 DEG C.
Preferably, in step (2), described acidifying is that to adjust condensation product to pH through dilute sulfuric acid be 1~2, then is passed through It is filtrated to get described mefenamic acid.
Compared with prior art, the invention has the advantages that:
The present invention is used as catalyst in the synthesis of mefenamic acid using manganese powder or manganese salt first, hence it is evident that reduce pair The generation of reaction, while reducing tar yield, hence it is evident that improve product appearance.
Use DMF, DMSO or sulfolane etc. for reaction dissolvent in the present invention, improve the yield of product;Also introduce benzene or Toluene substantially reduces the time of condensation reaction as dehydrating agent.
Embodiment
With reference to specific embodiment, the present invention is described further, but protection scope of the present invention is not limited in This:
The preparation of the mefenamic acid of embodiment 1
10gDMF is put into 250mL four-hole boiling flasks, 80 DEG C are warming up to, 27g 0-chloro-benzoic acids are put into, until adjacent chlorobenzene first It is sour complete it is molten after, add 25g sodium carbonate and carry out into salt, 80 DEG C of insulation half an hour.Water knockout drum is connect, 25g toluene is added and carries out a point water, directly Separated to anhydrous.Catalyst acetic acid manganese 0.5g and 2,3- dimethylaniline 22.5g is put into afterwards, and temperature is maintained at 120~130 DEG C. Sample in HPLC and control, work as 0-chloro-benzoic acid<When 1%, 100mL water, plus dilute sulfuric acid regulation pH to 2 are added, suction filtration, drying is obtained About 39.5g pale solids, molar yield 94.8%, nuclear-magnetism detection data and reaction equation difference are as follows.
1H NMR(DMSO):δ2.10(s,3H,-CH3),2.28(s,3H,-CH3), 6.68~7.90 (m, 7H, Ar-H), 9.46(s,-NH).
The preparation of the mefenamic acid of embodiment 2
10gDMF is put into 250mL four-hole boiling flasks, 80 DEG C are warming up to, 27g 0-chloro-benzoic acids are put into, until adjacent chlorobenzene first It is sour complete it is molten after, add 25g sodium carbonate and carry out into salt, 80 DEG C of insulation half an hour.Water knockout drum is connect, 25g toluene is added and carries out a point water, directly Separated to anhydrous.Catalyst sulfuric acid manganese 0.5g and 2,3- dimethylaniline 22.5g is put into afterwards, and temperature is maintained at 120~130 DEG C. Sample in HPLC and control, work as 0-chloro-benzoic acid<When 1%, 100mL water, plus dilute sulfuric acid regulation pH to 2 are added, suction filtration, drying is obtained About 38.7g pale solids, molar yield 93.0%, nuclear-magnetism detection data are as follows:
1H NMR(DMSO):δ2.10(s,3H,-CH3),2.28(s,3H,-CH3), 6.68~7.90 (m, 7H, Ar-H), 9.46(s,-NH).

Claims (6)

1. a kind of synthetic method of mefenamic acid, it is characterised in that comprise the following steps:
(1) using 0-chloro-benzoic acid as raw material, in the presence of acid binding agent, using aprotic polar solvent, adjacent chlorobenzene first is obtained into salt Hydrochlorate;
(2) under dehydrating agent effect, using manganese acetate or manganese sulfate as catalyst, 0-chloro-benzoic acid salt and 2,3- dimethylaniline enter Row condensation reaction, then acidified obtain mefenamic acid.
2. the synthetic method of mefenamic acid according to claim 1, it is characterised in that
0-chloro-benzoic acid, 23 dimethyl aniline, the mass ratio of acid binding agent and catalyst are 1:0.8~1.0:0.8~1.2: 0.01~0.03;
The mass ratio of aprotic polar solvent and 0-chloro-benzoic acid is 0.3~0.5:1;
The mass ratio of dehydrating agent and 0-chloro-benzoic acid is 0.8~1.2:1.
3. the synthetic method of mefenamic acid according to claim 1 or 2, it is characterised in that in step (1), described ties up Sour agent is sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide.
4. the synthetic method of mefenamic acid according to claim 1 or 2, it is characterised in that in step (1), described is non- Proton polar solvent is DMF, DMSO or sulfolane.
5. the synthetic method of mefenamic acid according to claim 1 or 2, it is characterised in that in step (2), described is de- Aqua is benzene or toluene.
6. the synthetic method of mefenamic acid according to claim 1, it is characterised in that in step (2), the condensation reaction Temperature be 120~130 DEG C.
CN201610475862.9A 2016-06-24 2016-06-24 A kind of synthetic method of mefenamic acid Active CN105949075B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610475862.9A CN105949075B (en) 2016-06-24 2016-06-24 A kind of synthetic method of mefenamic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610475862.9A CN105949075B (en) 2016-06-24 2016-06-24 A kind of synthetic method of mefenamic acid

Publications (2)

Publication Number Publication Date
CN105949075A CN105949075A (en) 2016-09-21
CN105949075B true CN105949075B (en) 2017-11-07

Family

ID=56904070

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610475862.9A Active CN105949075B (en) 2016-06-24 2016-06-24 A kind of synthetic method of mefenamic acid

Country Status (1)

Country Link
CN (1) CN105949075B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107382754A (en) * 2017-07-10 2017-11-24 江苏倍合德化工有限公司 A kind of quick high-efficiency synthesis method for preparing mefenamic acid
MX2021003730A (en) 2018-09-28 2021-06-18 Univ Griffith Agents and methods for modulating pathogen activity.
CN110467538B (en) * 2019-09-20 2022-08-26 山东道可化学有限公司 Synthesis method of 2-methyl-4-methoxydiphenylamine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789442A (en) * 1971-10-01 1973-03-29 Ciba Geigy CHELATES TO COMBAT METAL DEFICIENCY PHENOMENA IN PLANTS
JPS62273939A (en) * 1986-05-22 1987-11-28 Mitsui Toatsu Chem Inc Production of dl-alanine
DE10219037A1 (en) * 2002-04-29 2003-11-06 Bayer Ag Production and use of iminodisuccinic acid ammonium metal salts
CN1458140A (en) * 2003-05-04 2003-11-26 厦门市先端科技有限公司 Process for preparing aniline and its derivatives
JP4188401B2 (en) * 2004-05-12 2008-11-26 出光興産株式会社 Aromatic amine derivative, organic electroluminescence device using the same, and method for producing aromatic amine derivative
CN100336794C (en) * 2006-01-19 2007-09-12 中山大学 N-arylation process with hydrazone as ligand in aqueous phase system
CN101475505B (en) * 2009-02-09 2012-08-01 宝鸡天新药业有限公司 Process for preparing mefenamic acid
CN101704761B (en) * 2009-10-23 2012-09-05 宁波斯迈克制药有限公司 Synthesis method of mefenamic acid
CN102344384B (en) * 2011-09-02 2013-10-16 德州博诚制药有限公司 Production method of mefenamic acid
CN103420863A (en) * 2013-03-25 2013-12-04 江苏海佳化工有限公司 Mefenamic acid short-process synthesis preparation and refining method

Also Published As

Publication number Publication date
CN105949075A (en) 2016-09-21

Similar Documents

Publication Publication Date Title
US9624185B1 (en) Method for preparing IDO inhibitor epacadostat
CN105949075B (en) A kind of synthetic method of mefenamic acid
CN103880625B (en) Method for preparing D, L-mandelic acid and derivative of D, L-mandelic acid
CN114805314B (en) Synthesis method of Entecavir
US10501629B2 (en) Process for the preparation of isosulfan blue
JP5395908B2 (en) Process for producing 4- (1-hydroxy-1-methylethyl) -2-propylimidazole-5-carboxylic acid ester
CN105218472B (en) A kind of preparation method of triazinone
CN106496038A (en) A kind of preparation method of 3 methyl, 2 nitrobenzoic acid of high selectivity
CN109553550B (en) Method for synthesizing dihydrooat alkaloid
CN102875463B (en) Synthesis method for high-quality and low-cost bispyrithione
CN110337434A (en) The method for preparing 2- cyanoimidazole compound
CN104418810A (en) New synthetic route of levosimendan
CN104262208A (en) Method for combined production of o-benzaldehyde sulfonic acid sodium salt and o-chlorobenzoic acid
CN103626695B (en) New method for preparing fluazinam by using mixed solvent as medium
CN109836425B (en) Preparation process of synthetic pemetrexed
CN106432547A (en) Method for preparing enoxaparin sodium through heparin benzyl ester
CN108558710B (en) Preparation method of N, N-dibutyl m-aminophenol
CN108164502B (en) Preparation method of 1, 3-propane sultone
CN111689881B (en) Synthetic method of azosemide intermediate
CN106967762A (en) A kind of preparation technology of high-purity sodium rabeprazole
CN115340513B (en) Preparation method of 2-methyl-3-methylmercapto furan
CN115611791B (en) Preparation method of sodium polydithio-dipropyl sulfonate
CN103086962A (en) Synthetic method for 5-chlorine-2,4-dyhydroxyl pyridine
CN102675310B (en) Method for preparing pyrazol heteroaromatic compound
CN114773262B (en) Synthesis method of 2-cyano-4-pyridine carboxylic acid methyl ester

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant